Esophageal cancer chemotherapy drug oxaliplatin reviews

By | March 19, 2012

Esophageal cancer chemotherapy drug oxaliplatin reviews
Comments oxaliplatin, oxaliplatin is the 3rd generation of lead drugs, preclinical and Phase I, E clinical study confirmed that prominent effect on colorectal cancer, ovarian cancer and non-Hodgkin's lymphoma good effect, blood toxicity was mild , no renal toxicity, high incidence of peripheral nerve toxicity, but is reversible, and with no cross-resistance with oxaliplatin, so clinical studies could be further expanded and used to determine their indications and in combination chemotherapy in the application.
There are reports of oxaliplatin plus fluorouracil continuous infusion for a little hospital treatment of advanced esophageal cancer , of which initial treatment and retreatment rates were those 63.6% (22/35), 46.2% (3 / 35).
Oxaliplatin reviews, the main side effects were neurotoxicity, bone marrow suppression, vomiting. No treatment-related deaths. That the remission rate of the program, relatively low toxicity, can be used as first-or second-line treatment of the cancer to use.

Leave a Reply

Your email address will not be published. Required fields are marked *